200 related articles for article (PubMed ID: 25352062)
21. SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation.
Summers DW; Gibson DA; DiAntonio A; Milbrandt J
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6271-E6280. PubMed ID: 27671644
[TBL] [Abstract][Full Text] [Related]
22. Involvement of lysosomes in the early stages of axon degeneration.
Zheng J; Yan T; Feng Y; Zhai Q
Neurochem Int; 2010 Feb; 56(3):516-21. PubMed ID: 20036294
[TBL] [Abstract][Full Text] [Related]
23. Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo.
Beirowski B; Babetto E; Gilley J; Mazzola F; Conforti L; Janeckova L; Magni G; Ribchester RR; Coleman MP
J Neurosci; 2009 Jan; 29(3):653-68. PubMed ID: 19158292
[TBL] [Abstract][Full Text] [Related]
24. Wld(S) reduces paraquat-induced cytotoxicity via SIRT1 in non-neuronal cells by attenuating the depletion of NAD.
Yu Q; Wang T; Zhou X; Wu J; Chen X; Liu Y; Wu D; Zhai Q
PLoS One; 2011; 6(7):e21770. PubMed ID: 21750730
[TBL] [Abstract][Full Text] [Related]
25. A local mechanism mediates NAD-dependent protection of axon degeneration.
Wang J; Zhai Q; Chen Y; Lin E; Gu W; McBurney MW; He Z
J Cell Biol; 2005 Aug; 170(3):349-55. PubMed ID: 16043516
[TBL] [Abstract][Full Text] [Related]
26. Degeneration of neuronal cell bodies following axonal injury in Wld(S) mice.
Wang AL; Yuan M; Neufeld AH
J Neurosci Res; 2006 Dec; 84(8):1799-807. PubMed ID: 17022038
[TBL] [Abstract][Full Text] [Related]
27. c-Jun N-terminal kinase (JNK)-mediated phosphorylation of SARM1 regulates NAD
Murata H; Khine CC; Nishikawa A; Yamamoto KI; Kinoshita R; Sakaguchi M
J Biol Chem; 2018 Dec; 293(49):18933-18943. PubMed ID: 30333228
[TBL] [Abstract][Full Text] [Related]
28. DLK Activation Synergizes with Mitochondrial Dysfunction to Downregulate Axon Survival Factors and Promote SARM1-Dependent Axon Degeneration.
Summers DW; Frey E; Walker LJ; Milbrandt J; DiAntonio A
Mol Neurobiol; 2020 Feb; 57(2):1146-1158. PubMed ID: 31696428
[TBL] [Abstract][Full Text] [Related]
29. Wallerian Degeneration Is Executed by an NMN-SARM1-Dependent Late Ca(2+) Influx but Only Modestly Influenced by Mitochondria.
Loreto A; Di Stefano M; Gering M; Conforti L
Cell Rep; 2015 Dec; 13(11):2539-2552. PubMed ID: 26686637
[TBL] [Abstract][Full Text] [Related]
30. Context-Specific Stress Causes Compartmentalized SARM1 Activation and Local Degeneration in Cortical Neurons.
Hinz FI; Villegas CLM; Roberts JT; Yao H; Gaddam S; Delwig A; Green SA; Fredrickson C; Adrian M; Asuncion RR; Cheung TK; Hayne M; Hackos DH; Rose CM; Richmond D; Hoogenraad CC
J Neurosci; 2024 Jun; 44(24):. PubMed ID: 38692735
[TBL] [Abstract][Full Text] [Related]
31. Wld S requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration.
Avery MA; Sheehan AE; Kerr KS; Wang J; Freeman MR
J Cell Biol; 2009 Feb; 184(4):501-13. PubMed ID: 19237597
[TBL] [Abstract][Full Text] [Related]
32. Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene.
Wishart TM; Paterson JM; Short DM; Meredith S; Robertson KA; Sutherland C; Cousin MA; Dutia MB; Gillingwater TH
Mol Cell Proteomics; 2007 Aug; 6(8):1318-30. PubMed ID: 17470424
[TBL] [Abstract][Full Text] [Related]
33. The SARM1 axon degeneration pathway: control of the NAD
Figley MD; DiAntonio A
Curr Opin Neurobiol; 2020 Aug; 63():59-66. PubMed ID: 32311648
[TBL] [Abstract][Full Text] [Related]
34. Pathological axonal death through a MAPK cascade that triggers a local energy deficit.
Yang J; Wu Z; Renier N; Simon DJ; Uryu K; Park DS; Greer PA; Tournier C; Davis RJ; Tessier-Lavigne M
Cell; 2015 Jan; 160(1-2):161-76. PubMed ID: 25594179
[TBL] [Abstract][Full Text] [Related]
35. SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration.
Ko KW; Milbrandt J; DiAntonio A
J Cell Biol; 2020 Aug; 219(8):. PubMed ID: 32609299
[TBL] [Abstract][Full Text] [Related]
36. Lack of the immune adaptor molecule SARM1 accelerates disease in prion infected mice and is associated with increased mitochondrial respiration and decreased expression of NRF2.
Ward A; Jessop F; Faris R; Shoup D; Bosio CM; Peterson KE; Priola SA
PLoS One; 2022; 17(5):e0267720. PubMed ID: 35507602
[TBL] [Abstract][Full Text] [Related]
37. WldS can delay Wallerian degeneration in mice when interaction with valosin-containing protein is weakened.
Beirowski B; Morreale G; Conforti L; Mazzola F; Di Stefano M; Wilbrey A; Babetto E; Janeckova L; Magni G; Coleman MP
Neuroscience; 2010 Mar; 166(1):201-11. PubMed ID: 20018231
[TBL] [Abstract][Full Text] [Related]
38. Axon degeneration: Mechanisms and implications of a distinct program from cell death.
Yan T; Feng Y; Zhai Q
Neurochem Int; 2010 Mar; 56(4):529-34. PubMed ID: 20117162
[TBL] [Abstract][Full Text] [Related]
39. Expression of the neuroprotective slow Wallerian degeneration (WldS) gene in non-neuronal tissues.
Wishart TM; Brownstein DG; Thomson D; Tabakova AM; Boothe KM; Tsao JW; Gillingwater TH
BMC Neurosci; 2009 Dec; 10():148. PubMed ID: 20015399
[TBL] [Abstract][Full Text] [Related]
40. Live imaging reveals the cellular events downstream of SARM1 activation.
Ko KW; Devault L; Sasaki Y; Milbrandt J; DiAntonio A
Elife; 2021 Nov; 10():. PubMed ID: 34779400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
